News

Blog y noticias

blog-encarna-youtube-video-1200x675.png
20/Nov/2024

We are thrilled to announce that the highly anticipated webinar led by the renowned veterinary ophthalmologist Encarna Muñoz González is now available on our official YouTube channel. This engaging and insightful session, which took place on November 12, attracted over 90 live attendees and 300 registrations for future viewings, highlighting the significant interest in this vital topic.

Encarna shared her extensive knowledge about the role of nutraceuticals in managing retinopathies in small animals. Here’s why you shouldn’t miss the opportunity to watch this valuable resource:

What Was Covered in the Webinar?

Retinal Physiology and Common Retinopathies
Encarna provided a detailed explanation of the retina’s structure and its crucial role in vision. The session covered common retinal diseases, their pathophysiology, and how veterinarians can identify them early.

Diagnosis of Retinopathies
The webinar offered practical advice on how to diagnose retinal diseases, catering to both general practitioners and specialists. Key diagnostic tools such as fundus examination and electroretinography were highlighted.

The Role of Nutraceuticals in Retinal Health
Encarnación discussed the scientific evidence supporting the use of nutraceuticals like Retinae and Retinae XL. She emphasized their antioxidant and neuroprotective properties, which can help slow the progression of degenerative retinal conditions.

 

Where Can You Watch the Webinar?

The video is available on our YouTube channel, complete with reviewed English and Spanish subtitles, ensuring accessibility for our global audience.

Watch the Webinar on YouTube Now!

 

What’s Next?

As part of our commitment to continuing education, Dr+Vet by Andersen is already planning an exciting lineup of webinars for 2025. Stay tuned for announcements and make sure to join us for more opportunities to learn from leading experts in veterinary ophthalmology.

 

Thank you to all who participated in making this webinar a success. Your engagement motivates us to continue providing free, high-quality educational content for the veterinary community.

Share your feedback in the comments and let us know which topics you’d like us to cover in future sessions!


encarna-banner-blog-QR-1200x675.png
14/Oct/2024

Encarna Muñoz (Ars veterinaria / Vetervisión) will be the second speaker in the Dr+Vet by AndersenPets webinars

At Dr+Vet by Andersen we continue our commitment to quality training and we are delighted to present Encarnación Muñoz as a speaker in our next webinar for clinical veterinarians. The webinars organized by Dr+Vet by Andersen are designed to offer accessible and practical training on veterinary ophthalmology.
On this occasion, Encarna will guide us through a complete tour of the retinopathies that affect our patients. With an introduction to essential topics such as retinal anatomy, neuroprotection and the impact of oxidative stress, she will delve into key questions such as: How to diagnose retinopathies both at a generalist and specialized level? and What role do nutraceuticals play in the management of these pathologies?

Through current scientific studies, Encarna will show us how nutraceuticals can be a valuable tool in the management of retinal degeneration.

The speaker:

Encarna (LMV, BSAVA PGCertOphthal, MRCVS) graduated in Veterinary Medicine at the Complutense University of Madrid in 2014, subsequently obtaining a Postgraduate Degree in Veterinary Ophthalmology. After working as a Veterinary Surgeon in the UK for four years and stays in specialized hospitals, she returned to Spain in 2020 to continue her training at the Instituto Veterinario Oftalmológico de Barcelona.

In 2022, she completed her Postgraduate Certificate in Small Animal Ophthalmology with the BSAVA. Currently, she works as an ophthalmologist at AniCura Ars Veterinaria in Barcelona, in addition to collaborating as an itinerant in other clinics in the city.

Encarna is a member of RCVS, BrAVO and SEOVET, and actively participates in veterinary ophthalmology congresses.

Webinar Details
Date: November 12, 2024
Time: 13:00h CET
Duration: 90 minutes (60′ talk + 30′ questions)

Register here and participate for free in this educational webinar. We look forward to seeing you!


blog-retinae-1-1200x675.png
14/May/2024

We can now announce the new presentation of Retinae!

Retinae, our innovative nutraceutical product designed to be used as an adjuvant in the treatment of retinopathies, now comes in a new presentation: RetinaeXL!

What is RetinaeXL?

We have listened to the comments of many veterinarians, who told us that the usual presentation “was too small” for dogs of 30 or 40kg. So we set to work to formulate and create RetinaeXL. Its formula with twice the concentration of Retinae is specially designed for large and giant breed dogs.

How does RetinaeXL work?

Like standard Retinae, RetinaeXL is formulated with a combination of carotenoids, omega-3 fatty acids, vitamins, minerals and lactoferrin, all of which are known to have beneficial effects on eye health. However, RetinaeXL’s improved formula allows for more convenient and economical dosing for larger dogs.

The dosage of RetinaeXL is specifically adapted to larger dogs. It is recommended to administer one tablet of RetinaeXL per 20 kg body weight of the dog. This improved dosing facilitates handling and ensures accurate administration of the product, resulting in greater convenience and efficacy for caregivers and their pets.

The benefits of RetinaeXL:

Convenient and economical dosing: Dosing tailored to larger dogs makes handling easier and reduces costs associated with treatment, providing a more economical and efficient option for caregivers.
Same quality and safety: RetinaeXL maintains the high quality and safety standards that have made Retinae a trusted choice for pet eye care.

Where to get RetinaeXL?

RetinaeXL will be available from June at different distributors and veterinary clinics.

If you have any questions, please contact us at drvet@groupandersen.com


Copyright by Böthmen Pharma 2023. All rights reserved.